Evidence map›Paper›PMID 30414275›Full record

Trial reportInternational journal of cosmetic science2019

Cosmetic benefit of a biomimetic lamellar cream formulation on barrier function or the appearance of fine lines and wrinkles in randomized proof-of-concept clinical studies.

S Nisbet, H Mahalingam, C F Gfeller, E Biggs, S Lucas, M Thompson, M R Cargill, D Moore, S Bielfeldt

2 registry-linked trialsOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of cosmetic science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03180645 nacompletednot on this map

A Proof of Concept (POC) Clinical Study to Evaluate the Appearance of Fine Lines and Wrinkles on a Developmental Cosmetic Moisturising Cream in Healthy Subjects Presenting Visible Signs of Ageing

TypeinterventionalSponsorGlaxoSmithKlineRan2017 to 2017Enrolled72ConditionsSkin AgingArmsTest product (Moisturising cream), Positive control (Commercial market place moisturising cream), No treatment
NCT03216265 nacompletednot on this map

A Proof of Concept (POC) Clinical Study to Investigate the Effects of a Developmental Cosmetic Moisturising Cream on the Barrier Function of Human Skin on the Face and Forearm

TypeinterventionalSponsorGlaxoSmithKlineRan2017 to 2017Enrolled69ConditionsSkin CareArmsTest product (Moisturising cream), Positive control (Commercial market place moisturising cream), No treatment
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

S NisbetGlaxoSmithKline Consumer Healthcare, Medical Affairs - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K.
H MahalingamGlaxoSmithKline Consumer Healthcare, Medical Affairs - Skin Health, 184 Liberty Corner Road, Warren, NJ 07059, U.S.A.
C F GfellerGlaxoSmithKline Consumer Healthcare, Medical Affairs - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K.
E BiggsGlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K.
S LucasGlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K.
M ThompsonGlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K.
M R CargillGlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K.
D MooreGlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K.
S BielfeldtproDERM Institute for Applied Dermatological Research, Kiebitzweg 2, Schenefeld/Hamburg, 22869, Germany.
GlaxoSmithKline (United Kingdom) · GBDermatologikum Hamburg · DEGlaxoSmithKline (United States) · US

Funding

GlaxoSmithKline
6 · The paper itself

Abstract

objectiveTwo studies were designed to evaluate the potential cosmetic benefit of a biomimetic, niacinamide-containing moisturizing cream for the first time in humans.

methodsIn both studies, healthy women were randomized to use two treatments, one for the left side of the body and one for the right, from three options: the test cream, a positive control or no treatment (use of standard cleanser only). Treatments were applied twice daily for 4 weeks to the face and forearms (Study 1) or the face only (Study 2). Instrumental and clinical skin assessments were performed by trained technicians. Study 1 involved tape stripping and a 5-day no-treatment ('regression') period at the end of the 4 weeks. Independent lay graders were asked to grade the skin texture of subjects in Study 2 from high-resolution photographs.

resultsIn Study 1 (n = 66), the test cream significantly decreased the transepidermal water loss (TEWL) values on the forearm, and in the cheek area of the face, relative to baseline and compared to no treatment, and increased skin Corneometer values. The improvements were partially retained during a subsequent 5-day period of no treatment. Increases in TEWL values on skin subjected to tape stripping were significantly lower after 4 weeks of using the test cream compared to no treatment. In Study 2 (n = 72 subjects with visible signs of ageing), there was a favourable trend in the change from baseline of a skin roughness parameter, R

conclusionTwice daily application of the test cream over 4 weeks had beneficial effects on skin barrier function, moisturization, wrinkle dimensions and elasticity compared to no treatment. These studies provide proof-of-concept evidence and highlight the cosmetic benefit of the biomimetic lamellar cream formulation. STUDY REGISTRATION: NCT03216265, NCT03180645.

Indexed as

BiomimeticsCosmeticsSkin CreamAdolescentAdultAgedFemaleHumansMiddle AgedNiacinamidePermeabilityProof of Concept StudySkin AgingSkin Physiological PhenomenaYoung AdultCosmeticsNiacinamideemulsionsfine linesformulation/stabilitymoisturizing lamellar creamskin barrierwrinkles

Identifiers

PMID30414275
PMCPMC6849859
OpenAlexW2899540513

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.